This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Fenwick Releases Inaugural Technology And Life Sciences IPO Survey

MOUNTAIN VIEW, Calif., March 29, 2013 /PRNewswire/ -- Today, law firm Fenwick & West announced the release of the firm's inaugural IPO Survey, "Key Metrics for Recent Technology and Life Science Initial Public Offerings." The IPO survey is the first in a series that will provide quarterly reviews of IPOs in the technology and life sciences sectors nationwide. 

"We developed the survey with technology and life sciences companies in mind, as well as others who are interested in IPO activities for these companies, as a way to provide a graphical overview of key parameters as well as a sense of recent trends and activity," said Fenwick partners and survey co-authors, Daniel Winnike and Jeffrey Vetter.

Fenwick's IPO survey reveals a number of key findings including the following insights:

  • The post-Lehman market peaked in Q2 2011 and Q2 2012 only to slow in Q3 each year due to concerns over the EU sovereign debt crisis and extreme market volatility. 
  • As a result of the market turmoil in the summer of 2011, many IPOs were put on hold and pushed into 2012, setting the stage for a strong start in 2012.
  • 2012 was regarded by many as a strong year for technology and life sciences IPOs. Even so, there were fewer deals in 2012 than in 2007 and a fraction of the number in 1998.
  • Many factors contribute to the smaller number of offerings in recent years, including the increased cost of going public in light of SOX and other enhanced regulatory requirements, fewer underwriters of sub $50M IPOs that were much more prevalent in the 1990's IPO market and the decimalization of the stock market.
  • Forward looking, the question has become - Is there a strong pipeline heading into Q2 2013 similar to the lead into 2012?

Fenwick has a long history of working in capital markets having represented more than 150 issuers and underwriters in initial public offerings. In the past two years alone, the firm worked on many IPOs including:  Silver Spring Networks, Model N, Marin Software, Workday, ServiceNow, Facebook, Infoblox, Proofpoint, Vocera, Jive Software, Zillow.com, Fusion-io and Responsys.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs